Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tobias Hillemacher"'
Autor:
Florian Janisch, Christina Kienapfel, Constantin Fühner, Thomas Klotzbücher, Phillip Marks, Tobias Hillemacher, Christian P. Meyer, Takehiro Iwata, Mehdi Kardoust Parizi, Guido Sauter, Margit Fisch, Shahrokh F. Shariat, Roland Dahlem, Michael Rink
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patie
Externí odkaz:
https://doaj.org/article/46f83ba3e8464463b86b544dabfebe2d
Autor:
David D'Andrea, Florian Janisch, Christian Meyer, Tobias Hillemacher, Malte W. Vetterlein, Margit Fisch, Michael Rink, Constantin Fuehner, Shoji Kimura, Shahrokh F. Shariat, Roland Dahlem, Mohammad Abufaraj, Christina Kienapfel, Thomas Klotzbücher
Publikováno v:
Urologic oncology. 38(9)
Background Tyrosine kinase inhibitor therapy (TKI) has changed the treatment paradigm of metastatic renal cell carcinoma (mRCC). The recent CARMENA and SURTIME trials challenged the role of the cytoreductive nephrectomy (CN). Objective To assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccbcca9d96f72bff5a8bc4af2735485
https://pubmed.ncbi.nlm.nih.gov/32576526
https://pubmed.ncbi.nlm.nih.gov/32576526
Autor:
Shahrokh F. Shariat, Christina Kienapfel, Roland Dahlem, Thomas Klotzbücher, Florian Janisch, Tobias Hillemacher, Michael Rink, Margit Fisch, Christian Meyer, Malte W. Vetterlein, Constantin Fühner
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:While cytoreductive nephrectomy (CN) was standard of care for a decade, the results of the CARMENA trial have challenged the role of CN in the multi-kinase receptor inhi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef3ce25cd4e73965d953d9284cf4bba6
https://doi.org/10.1097/01.ju.0000555650.35591.8b
https://doi.org/10.1097/01.ju.0000555650.35591.8b
Autor:
Constantin Fühner, Michael Rink, Florian Janisch, Thomas Klotzbücher, Christian Meyer, Christina Kienapfel, Shahrokh F. Shariat, Roland Dahlem, Margit Fisch, Tobias Hillemacher, Phillip Marks
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:The introduction of tyrosine-kinase inhibitors (TKI) fundamentally changed the natural history and outcomes of patients with metastatic renal-cell cancer (mRCC). Clear c...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6848eb112b28728258f903e45b7e2e1
https://doi.org/10.1097/01.ju.0000555649.35591.5d
https://doi.org/10.1097/01.ju.0000555649.35591.5d